Berger, M. R., I. Tsoneva, S. M. Konstantinov and H. Eibl: Induction of apoptosis by erucylphospho-N,N,N-trimethylammonium is associated with changes in signal molecule expression and location. In: Apoptosis: From signaling pathways to therapeutic tools. Annals of the New York Academy of Sciences 1010. New York Acad. Ssc., New York (2003) 307-310.
Konstantinov, S. M., M. C. Georgieva, M. Topashka-Ancheva, H. Eibl and M. R. Berger: Combination with an antisense oligonucleotide synergistically improves the antileukemic efficacy of erucylphospho-N,N,N- trimethylpropylammonium in chronic myeloid leukemia cell lines. In: Molecular Cancer Therapeutics 1, 10, 877-884 (2002).
Konstantinov, S. M., H. Eibl and M. R. Berger: BCR-ABL influences the antileukaemic efficacy of alkylphosphocholines.. In: British Journal of Haematology 107, 365-374 (1999).
localid: 11516
Berger, M. R., S. Sobottka, S. M. Konstantinov and H. Eibl: Erucylphosphocholine is the prototype of i. v. injectable alkylphosphocholines.. In: Drugs of Today 34 (Suppl. F), 73-81 (1998).
localid: 657
Konstantinov, S. M., H. Eibl and M. R. Berger: Alkylphosphocholines induce apoptosis in HL-6+ and U-937 leukemic cells.. In: Cancer Chemotherapy and Pharmacology 41, 210-216 (1998).
localid: 663
Kaufmann-Kolle, P., J. Drevs, M. R. Berger, J. Koetting, N. Marschner, C. Unger and H. Eibl: Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine. In: Cancer Chemotherapy and Pharmacology 34, 5, 393-398 (1994).
Koetting, J., M. R. Berger, C. Unger and H. Eibl: ALKYLPHOSPHOCHOLINES - INFLUENCE OF STRUCTURAL VARIATION ON BIODISTRIBUTION AT ANTINEOPLASTICALLY ACTIVE CONCENTRATIONS. In: Cancer Chemotherapy and Pharmacology 30, 2, 105-112 (1992).
Berger, M. R., P. Yanapirut, M. Reinhardt, T. Klenner, H. R. Scherf, H. H. Schmeiser and H. Eibl: ANTITUMOR-ACTIVITY OF ALKYLPHOSPHOCHOLINES AND ANALOGS IN METHYLNITROSOUREA-INDUCED RAT MAMMARY CARCINOMAS. In: Progress in Experimental Tumor Research 34, 98-115 (1992).
Berger, M. R., H. Richter, M. H. Seelig, H. Eibl and D. Schmahl: NEW CYTOSTATICS - MORE ACTIVITY AND LESS TOXICITY. In: Cancer Treatment Reviews 17, 2-3, 143-154 (1990).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.